Zealand Pharma A/S announced the appointment of Henriette Wennicke as Zealand's Chief Financial Officer starting November 1, 2022. Henriette Wennicke comes to Zealand with broad finance and business experience at large organizations, including in healthcare, where she has led financial planning and R&D portfolio management. She is currently the Vice President and Head of Investor Relations and Treasury at GN Store Nord, a global leader in intelligent audio solutions, listed on the Nasdaq Copenhagen.

Previously, Henriette Wennicke was Vice President and Head of Global Finance at GN Hearing. Henriette Wennicke started her career at Novo Nordisk, where she held various finance positions of increasing responsibility within the R&D organization during her 10-year tenure. Henriette Wennicke holds an M.Sc.

in Finance and Strategic Management from Copenhagen Business School. She will succeed Matthew Dallas, who joined Zealand as CFO in 2019, and will leave the company at the end of August. Lykke Rømer, Vice President, Head of Finance and Accounting will assume the responsibilities of the CFO on an interim basis.